Emphasising their desire to move the drug forward, in a separate announcement made
directly to the HD community, Ionis said «Upon study completion, the next step for this program will be to conduct a study to investigate if decreasing
mutant huntingtin protein with IONIS - HTTRx can slow the progression of this terrible disease.»